SEC Form 4 · accession 0001179110-17-007877
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett K Haumann
Officer — SVP Clin Dev & Chief Med Ofc
Period of report
May 20, 2017
Accepted (ET)
May 23, 2017 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 20, 2017 | F | 7,065 | $36.83 | D | 156,406 | D |
Table II — derivative securities
No Table II lines on this filing.